Medical News

RSS

Inovio’s novel platform for developing DNA based vaccines to be discussed at EmTech

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, CEO, has been invited to present at EmTech, the Emerging Technologies Conference hosted by MIT and produced by MIT’s Technology Review magazine. The conference will take place September 22nd - 24th on the MIT campus in Cambridge, MA.

16 Sep 2009

Newly developed model helps early diagnosis of postnatal depression

Worldwide, 13% of women who give birth suffer from postnatal depression, which causes a significant deterioration in a mother's quality of life and her ability to care for her baby. Now, Spanish researchers have developed a model to diagnose this illness with a predictive power of 80% - the best result to date for this kind of depression.

16 Sep 2009

CEL-SCI to commence its LEAPS-H1N1 clinical trial following FDA approval

CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today that the U.S. Food and Drug Administration (FDA) has indicated that the Company can proceed with its first clinical trial to evaluate the effect of its investigational LEAPS-H1N1 treatment on the white blood cells of hospitalized H1N1 patients.

16 Sep 2009

BioCision's partnership with Therapak for distributing its products in clinical market

BioCision LLC, the CoolRack company, today announced that it has entered into an agreement with Therapak Corporation for the distribution of BioCision’s products into the clinical market. The deal marks BioCision’s first distribution agreement for the clinical market and expands its access to clinical settings across the United States and Europe.

16 Sep 2009

NCR offers DigitalPersona's U.are.U 4500HD fingerprint sensor

DigitalPersona, Inc., a leader in fingerprint identity and authentication solutions, today announced that NCR Corporation is now offering DigitalPersona's U.are.U 4500HD "heavy duty" fingerprint sensor as an option on NCR's next-generation integrated point-of-sale (POS) workstation, the NCR RealPOS 70XRT.

16 Sep 2009

The relationship between pain and age related disability

Younger people with pain look similar in terms of their disability to people who are two to three decades older without pain, according to a study published in this month's issue of the Journal of the American Geriatric Society. The results of the study uncovered that people with pain develop the functional limitations classically associated with aging at much earlier ages.

16 Sep 2009

Study links reminders of money, social exclusion and physical pain

In a paper evaluated by f1000 Medicine, six studies tested relationships between reminders of money, social exclusion and physical pain.

16 Sep 2009

Celsion's DIGNITY clinical trial aired on Good Morning America

Celsion Corporation announced today the Company’s DIGNITY clinical trial evaluating the use of ThermoDox in combination with hyperthermia for the treatment of Recurrent Chest Wall (RCW) Breast Cancer was aired during commercial breaks on Good Morning America and CBS Sunday Morning this past weekend.

16 Sep 2009

Aptuit obtains the CEO Cancer Gold Standard accreditation

Aptuit, Inc. has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines.

16 Sep 2009

Nutrition and exercise program for children

While research shows many American children become more sedentary in adolescence, a nationwide program - Triple Play - is reversing the trend by motivating them to be more physically active, according to a report released today.

16 Sep 2009

Santaris Pharma establishes its operations in the U.S.

Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced it has established operations in the United States. Internally and through its partners, the Company has a robust drug development pipeline including programs to treat metabolic disorders, infectious and inflammatory diseases, cancer and rare genetic disorders.

16 Sep 2009

First Edition: September 16, 2009

Today's biggest story -- Senate Finance Committee Chair Max Baucus, D-Mont., will unveil his health reform proposals. Who will support it? And won't?

16 Sep 2009

Medivir presented preclinical data from its cathepsin K inhibitor program at the ASBMR meeting

Medivir (STO:MVIRB) presented preclinical data on two candidate drugs (MIV-710, MIV-711) from its cathepsin K inhibitor program in a poster session during the ASBMR (American Society for Bone and Mineral Research) meeting.

16 Sep 2009

Checklists for improved patient safety

A new report, involving the University of Leicester, has called for greater understanding of how checklists can be used to improve safety. The report has been described as "counter-revolutionary" and providing a "a long overdue and desperately needed reality check for checklists in medicine" by Faculty of 1000 Medicine.

16 Sep 2009

Paradigm's CMO receives 2009 Risk Innovator Award

Risk & Insurance magazine today recognized Paradigm Management Services' Chief Medical Officer and founder, 2009 Risk Innovator Awards.

16 Sep 2009

Decision Resources forecasts sales of Rituxan/MabThera, Erbitux and Herceptin

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that U.S. and European (France, Germany, Italy, Spain and U.K.) sales of Roche/Biogen Idec's Rituxan/MabThera, Bristol-Myers Squibb/Merck's Erbitux and Roche's Herceptin will peak at almost $16 billion in 2014, before falling to roughly $10 billion in 2018.

16 Sep 2009

Winner of LA's Best Award 2009

Los Angeles dentist, Dr. Sam Muslin, DDS, MAGD, has been awarded LA's Best Award (tm) 2009 for his leading edge, high quality dentistry.

16 Sep 2009

Understanding Mexico's management of the A(H1N1) outbreak

When the hitherto undetected A(H1N1) influenza attacked Mexico explosively in late April 2009, the world watched with critical attention as that country's leaders scrambled to manage the emerging public health crisis.

16 Sep 2009

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has enhanced its capabilities to provide medical imaging measurements for osteoarthritis clinical trials through an alliance with Optasia Medical, Inc.

From Parexel 16 Sep 2009